{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:53:04Z","timestamp":1789239184192,"version":"build-2803163510"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100494","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T19:04:41Z","timestamp":1637435081000},"page":"100494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Aging-associated immune system changes in multiple myeloma: The dark side of the moon."],"prefix":"10.1016","volume":"29","author":[{"given":"Alissa","family":"Visram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taxiarchis V.","family":"Kourelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0001","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/leu.2011.196","article-title":"Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study","volume":"26","author":"Kumar","year":"2012","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.ctarc.2021.100494_bib0003","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1634\/theoncologist.2016-0104","article-title":"Analysis of real-world data on overall survival in multiple myeloma patients with >\/=3 prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory drug (IMiD), or double refractory to a PI and an IMiD","volume":"21","author":"Usmani","year":"2016","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0004","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"Keats","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0005","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1038\/s41375-018-0153-6","article-title":"Multiple myeloma clonal evolution in homogeneously treated patients","volume":"32","author":"Corre","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0006","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0007","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s13238-020-00762-2","article-title":"A human circulating immune cell landscape in aging and COVID-19","volume":"11","author":"Zheng","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.ctarc.2021.100494_bib0008","doi-asserted-by":"crossref","unstructured":"Cheung, P., et\u00a0al., Single-cell chromatin modification profiling reveals increased epigenetic variations with aging. cell, 2018. 173(6): p. 1385\u20131397 e14.","DOI":"10.1016\/j.cell.2018.03.079"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0009","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.molmed.2010.03.003","article-title":"Inflammatory networks during cellular senescence: causes and consequences","volume":"16","author":"Freund","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ctarc.2021.100494_bib0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"26","key":"10.1016\/j.ctarc.2021.100494_bib0011","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.0503280102","article-title":"Cell intrinsic alterations underlie hematopoietic stem cell aging","volume":"102","author":"Rossi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U S A,"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0012","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1189\/jlb.0805481","article-title":"Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions","volume":"79","author":"Fortin","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0013","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10522-006-9067-1","article-title":"GM-CSF activates the Jak\/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals","volume":"8","author":"Fortin","year":"2007","journal-title":"Biogerontology"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0014","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood-2013-08-519520","article-title":"Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence","volume":"123","author":"Sapey","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/gerona\/glw062","article-title":"Reduced oxidative burst by primed neutrophils in the elderly individuals is associated with increased levels of the CD16bright\/CD62Ldim immunosuppressive subset","volume":"72","author":"Sauce","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0016","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10875-010-9448-8","article-title":"Impaired functions of peripheral blood monocyte subpopulations in aged humans","volume":"30","author":"Nyugen","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mad.2003.11.010","article-title":"Macrophage hypo-responsiveness to interferon-gamma in aged mice is associated with impaired signaling through Jak-STAT","volume":"125","author":"Yoon","year":"2004","journal-title":"Mech. Ageing Dev."},{"issue":"2\u20133","key":"10.1016\/j.ctarc.2021.100494_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0531-5565(01)00205-4","article-title":"Immunosenescence of macrophages: reduced MHC class II gene expression","volume":"37","author":"Herrero","year":"2002","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0019","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1189\/jlb.0803389","article-title":"Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression","volume":"75","author":"Boehmer","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ctarc.2021.100494_bib0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2172-11-30","article-title":"Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults","volume":"11","author":"Seidler","year":"2010","journal-title":"BMC Immunol."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100494_bib0021","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0531-5565(99)00065-0","article-title":"Phenotypic and functional characteristics of circulating monocytes of elderly persons","volume":"34","author":"Sadeghi","year":"1999","journal-title":"Exp. Gerontol."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0022","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00018-019-03048-x","article-title":"Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency","volume":"76","author":"Salminen","year":"2019","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0023","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/acel.12571","article-title":"Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-kappaB-dependent mechanism","volume":"16","author":"Flores","year":"2017","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0024","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1332","article-title":"T cell- and B cell-independent adaptive immunity mediated by natural killer cells","volume":"7","author":"O'Leary","year":"2006","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","article-title":"Human NK cells display major phenotypic and functional changes over the life span","volume":"9","author":"Le Garff-Tavernier","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.ctarc.2021.100494_bib0026","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fimmu.2017.00896","article-title":"Role of dendritic cells in inflammation and loss of tolerance in the elderly","volume":"8","author":"Agrawal","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2249.1992.tb07954.x","article-title":"Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population","volume":"90","author":"Paganelli","year":"1992","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0028","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.4049\/jimmunol.171.5.2326","article-title":"The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors","volume":"171","author":"Miller","year":"2003","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ctarc.2021.100494_bib0029","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.4049\/jimmunol.161.9.4472","article-title":"Senescent BALB\/c mice exhibit decreased expression of lambda5 surrogate light chains and reduced development within the pre-B cell compartment","volume":"161","author":"Sherwood","year":"1998","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.ctarc.2021.100494_bib0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0047-6374(00)00157-3","article-title":"The reduced expression of surrogate light chains in B cell precursors from senescent BALB\/c mice is associated with decreased E2A proteins","volume":"118","author":"Sherwood","year":"2000","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1474-9726.2008.00443.x","article-title":"B-cell diversity decreases in old age and is correlated with poor health status","volume":"8","author":"Gibson","year":"2009","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0032","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.4049\/jimmunol.1501209","article-title":"Age-associated B cells: a T-bet-dependent effector with roles in protective and pathogenic immunity","volume":"195","author":"Rubtsova","year":"2015","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0033","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1182\/blood-2011-01-330530","article-title":"A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice","volume":"118","author":"Hao","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2021.100494_bib0034","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fimmu.2017.00982","article-title":"Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity","volume":"8","author":"Franceschi","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0035","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.181.3.1835","article-title":"Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation","volume":"181","author":"Lages","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0036","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/acel.12552","article-title":"Phenotypic characteristics of aged CD4(+) CD28(null) T lymphocytes are determined by changes in the whole-genome DNA methylation pattern","volume":"16","author":"Suarez-Alvarez","year":"2017","journal-title":"Aging Cell"},{"issue":"22","key":"10.1016\/j.ctarc.2021.100494_bib0037","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1073\/pnas.0601040103","article-title":"Thymic output in aged mice","volume":"103","author":"Hale","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U S A,"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0038","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2012.02.006","article-title":"Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans","volume":"36","author":"den Braber","year":"2012","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0039","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4049\/jimmunol.1301721","article-title":"Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans","volume":"192","author":"Wertheimer","year":"2014","journal-title":"J. Immunol."},{"issue":"52","key":"10.1016\/j.ctarc.2021.100494_bib0040","doi-asserted-by":"crossref","first-page":"21432","DOI":"10.1073\/pnas.1209283110","article-title":"Peripheral selection rather than thymic involution explains sudden contraction in naive CD4 T-cell diversity with age","volume":"109","author":"Johnson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A,"},{"key":"10.1016\/j.ctarc.2021.100494_bib0041","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-4933-5-6","article-title":"Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people","volume":"5","author":"Koch","year":"2008","journal-title":"Immun. Ageing"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0042","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2004-11-4469","article-title":"Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8+ T cells during persistent infection","volume":"106","author":"Dunne","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0043","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.exger.2003.10.028","article-title":"Paradoxical age-related cell cycle quickening of human CD4(+) lymphocytes: a role for cyclin D1 and calpain","volume":"39","author":"Witkowski","year":"2004","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12675","article-title":"Human CD8(+) EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK","volume":"17","author":"Callender","year":"2018","journal-title":"Aging Cell"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ni.2981","article-title":"The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells","volume":"15","author":"Lanna","year":"2014","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.ctarc.2021.100494_bib0046","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1172\/JCI118638","article-title":"CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity","volume":"97","author":"Schmidt","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0047","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0048","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41590-020-0643-3","article-title":"Sestrins induce natural killer function in senescent-like CD8(+) T cells","volume":"21","author":"Pereira","year":"2020","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0049","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.167.6.3231","article-title":"Down-regulation of CD28 expression by TNF-alpha","volume":"167","author":"Bryl","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0050","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1002\/art.21353","article-title":"Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis","volume":"52","author":"Bryl","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"28","key":"10.1016\/j.ctarc.2021.100494_bib0051","doi-asserted-by":"crossref","first-page":"29130","DOI":"10.1074\/jbc.M402194200","article-title":"Tumor necrosis factor-alpha and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription","volume":"279","author":"Lewis","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0052","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1065-6995(03)00170-7","article-title":"FasL-induced downregulation of CD28 expression on jurkat cells in vitro is associated with activation of caspases","volume":"27","author":"Ma","year":"2003","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0053","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0531-5565(03)00166-9","article-title":"Hydrogen peroxide induced down-regulation of CD28 expression of Jurkat cells is associated with a change of site alpha-specific nuclear factor binding activity and the activation of caspase-3","volume":"38","author":"Ma","year":"2003","journal-title":"Exp. Gerontol."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100494_bib0054","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.4049\/jimmunol.0803449","article-title":"Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3","volume":"182","author":"Parish","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0055","doi-asserted-by":"crossref","first-page":"8415","DOI":"10.4049\/jimmunol.175.12.8415","article-title":"Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction","volume":"175","author":"Palmer","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100494_bib0056","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.ctarc.2021.100494_bib0057","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1182\/blood-2009-01-199588","article-title":"KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells","volume":"113","author":"Henson","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0058","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1182\/blood.V88.6.2219.bloodjournal8862219","article-title":"Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein","volume":"88","author":"Urashima","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0059","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1006\/cimm.1995.1076","article-title":"Interleukin-6 inhibits apoptosis of malignant plasma cells","volume":"162","author":"Lichtenstein","year":"1995","journal-title":"Cell. Immunol"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.leukres.2006.06.012","article-title":"Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression","volume":"31","author":"Kline","year":"2007","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0061","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4065\/84.2.114","article-title":"Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component","volume":"84","author":"Lust","year":"2009","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ctarc.2021.100494_bib0062","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bone.2016.07.007","article-title":"Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease","volume":"91","author":"Nyman","year":"2016","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0063","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.exphem.2010.06.012","article-title":"The cytokine\/chemokine pattern in the bone marrow environment of multiple myeloma patients","volume":"38","author":"Cao","year":"2010","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0064","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V90.4.1649","article-title":"Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells","volume":"90","author":"Barille","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0065","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/sj.leu.2402714","article-title":"Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells","volume":"16","author":"Arendt","year":"2002","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0066","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6600833","article-title":"Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3","volume":"88","author":"Vande Broek","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0067","doi-asserted-by":"crossref","first-page":"e58504","DOI":"10.1371\/journal.pone.0058504","article-title":"The systemic cytokine environment is permanently altered in multiple myeloma","volume":"8","author":"Zheng","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ctarc.2021.100494_bib0068","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9434637","article-title":"Peripheral blood lymphocyte-to-monocyte ratio as a useful prognostic factor in newly diagnosed multiple myeloma","volume":"2018","author":"Tian","year":"2018","journal-title":"Biomed Res. Int."},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0069","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41408-017-0019-6","article-title":"The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents","volume":"7","author":"Romano","year":"2017","journal-title":"Blood Cancer J."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100494_bib0070","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1038\/bcj.2017.60","article-title":"Significance of the absolute lymphocyte\/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma","volume":"7","author":"Dosani","year":"2017","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0071","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.immuni.2019.06.006","article-title":"Plasma cells are obligate effectors of enhanced myelopoiesis in aging bone marrow","volume":"51","author":"Pioli","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ctarc.2021.100494_bib0072","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.1203373","article-title":"Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow","volume":"190","author":"Ramachandran","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0073","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.2019004537","article-title":"Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma","volume":"136","author":"Perez","year":"2020","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.ctarc.2021.100494_bib0074","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","article-title":"Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans","volume":"121","author":"Gorgun","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2021.100494_bib0075","doi-asserted-by":"crossref","unstructured":"Kuwahara-Ota, S., et\u00a0al., Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma. Br. J. Haematol., 2020.","DOI":"10.1111\/bjh.16881"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0076","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3324\/haematol.2016.153841","article-title":"IL21R expressing CD14(+)CD16(+) monocytes expand in multiple myeloma patients leading to increased osteoclasts","volume":"102","author":"Bolzoni","year":"2017","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0077","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/iid3.53","article-title":"The proportion of CD16(+)CD14(dim) monocytes increases with tumor cell load in bone marrow of patients with multiple myeloma","volume":"3","author":"Sponaas","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.ctarc.2021.100494_bib0078","doi-asserted-by":"crossref","unstructured":"Konjevic, G., et\u00a0al., Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma. J. Clin. Pathol., 2016.","DOI":"10.1136\/jclinpath-2016-203614"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100494_bib0079","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2015-10-662320","article-title":"Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis","volume":"127","author":"Paiva","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0080","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJM199003083221005","article-title":"Markers of multiple hematopoietic-cell lineages in multiple myeloma","volume":"322","author":"Epstein","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100494_bib0081","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0025-6196(12)61350-0","article-title":"Cell surface markers in multiple myeloma","volume":"69","author":"Ruiz-Arguelles","year":"1994","journal-title":"Mayo Clin. Proc."},{"issue":"15","key":"10.1016\/j.ctarc.2021.100494_bib0082","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1182\/blood-2015-08-665679","article-title":"Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance","volume":"127","author":"Paiva","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2021.100494_bib0083","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1038\/cddis.2012.183","article-title":"Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells","volume":"3","author":"Cahu","year":"2012","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0084","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-016-0345-3","article-title":"T cells in multiple myeloma display features of exhaustion and senescence at the tumor site","volume":"9","author":"Zelle-Rieser","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2021.100494_bib0085","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/leu.2016.84","article-title":"Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade","volume":"30","author":"Suen","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100494_bib0086","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41408-019-0234-4","article-title":"Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies","volume":"9","author":"Kourelis","year":"2019","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ctarc.2021.100494_bib0087","doi-asserted-by":"crossref","unstructured":"Bailur, J.K., et\u00a0al., Early alterations in stem-like\/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy. JCI Insight, 2019. 5.","DOI":"10.1172\/jci.insight.127807"},{"issue":"8","key":"10.1016\/j.ctarc.2021.100494_bib0088","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.celrep.2019.01.085","article-title":"Mass cytometry analysis reveals that specific intratumoral CD4(+) T cell subsets correlate with patient survival in follicular lymphoma","volume":"26","author":"Yang","year":"2019","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0089","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/2326-6066.CIR-15-0055","article-title":"T-cell exhaustion in multiple myeloma relapse after autotransplant: optimal timing of immunotherapy","volume":"4","author":"Chung","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2021.100494_bib0090","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3389\/fimmu.2020.02153","article-title":"Conventional treatment for multiple myeloma drives premature aging phenotypes and metabolic dysfunction in T cells","volume":"11","author":"Cooke","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0091","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbmt.2019.08.009","article-title":"T cell transcriptional profiling and immunophenotyping uncover LAG3 as a potential significant target of immune modulation in multiple myeloma","volume":"26","author":"Lucas","year":"2020","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"15","key":"10.1016\/j.ctarc.2021.100494_bib0092","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/bloodadvances.2017005447","article-title":"Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT","volume":"1","author":"Ho","year":"2017","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0093","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/bmt.2015.143","article-title":"Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma","volume":"50","author":"Rosko","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0094","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cyto.a.23693","article-title":"High-parameter mass cytometry evaluation of relapsed\/refractory multiple myeloma patients treated with daratumumab demonstrates immune modulation as a novel mechanism of action","volume":"95","author":"Adams 3rd","year":"2019","journal-title":"Cytometry A"},{"key":"10.1016\/j.ctarc.2021.100494_bib0096","doi-asserted-by":"crossref","unstructured":"Casneuf, T., et\u00a0al., Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab. Leukemia, 2020.","DOI":"10.1038\/s41375-020-0855-4"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0097","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(19)30788-0","article-title":"Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study","volume":"21","author":"Lonial","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2021.100494_bib0098","doi-asserted-by":"crossref","unstructured":"Visram A., D.S., Anderson E., Kumar S.K., Kourelis T.V., Describing the cellular and humoral immune tumor microenvironment and malignant transcriptome across the multiple myeloma disease spectrum, in American Society of Hematology Annual Meeting. 2020, Blood: p. .","DOI":"10.1182\/blood-2020-142130"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0099","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41423-019-0344-8","article-title":"Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment","volume":"17","author":"Zhao","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri2959","article-title":"Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?","volume":"11","author":"Akbar","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0101","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.smim.2012.04.007","article-title":"Translational research in immune senescence: assessing the relevance of current models","volume":"24","author":"High","year":"2012","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0102","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41467-017-02689-5","article-title":"Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2021.100494_bib0103","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0104","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2012-03-416040","article-title":"Human regulatory T cells induce T-lymphocyte senescence","volume":"120","author":"Ye","year":"2012","journal-title":"Blood"},{"issue":"1\u20133","key":"10.1016\/j.ctarc.2021.100494_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.febslet.2004.07.083","article-title":"PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70\/CD3zeta signalosome and downstream signaling to PKCtheta","volume":"574","author":"Sheppard","year":"2004","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0106","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.1202369","article-title":"Tumor-derived gammadelta regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence","volume":"190","author":"Ye","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2021.100494_bib0107","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.ctarc.2021.100494_bib0108","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1172\/JCI75051","article-title":"p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells","volume":"124","author":"Henson","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0109","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bbmt.2017.11.027","article-title":"Increased coexpression of PD-1, TIGIT, and KLRG-1 on tumor-reactive CD8(+) T Cells during relapse after allogeneic stem cell transplantation","volume":"24","author":"Hutten","year":"2018","journal-title":"Biol. Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0110","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/eji.201445312","article-title":"Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways","volume":"45","author":"Henson","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0111","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"issue":"18","key":"10.1016\/j.ctarc.2021.100494_bib0112","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 during effector CD8 T cell differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0113","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.ctarc.2021.100494_bib0114","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1182\/bloodadvances.2019000600","article-title":"T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma","volume":"3","author":"Garfall","year":"2019","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2021.100494_bib0116","doi-asserted-by":"crossref","unstructured":"Leblay N., Maity R., Barakat E., McCulloch S., Duggan P., Jimenez-Zepeda V., Bahlis N., Neri P., Cite-Seq profiling of T Cells in multiple myeloma patients undergoing BCMA targeting CAR-T or bites immunotherapy, in American Society of Hematology Annual Meeting. 2020, Blood.","DOI":"10.1182\/blood-2020-137650"},{"issue":"29","key":"10.1016\/j.ctarc.2021.100494_bib0117","doi-asserted-by":"crossref","first-page":"20476","DOI":"10.18632\/oncotarget.24944","article-title":"Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation","volume":"9","author":"Fostier","year":"2018","journal-title":"Oncotarget"},{"issue":"58","key":"10.1016\/j.ctarc.2021.100494_bib0118","doi-asserted-by":"crossref","first-page":"98200","DOI":"10.18632\/oncotarget.21516","article-title":"Lenalidomide overcomes the immunosuppression of regulatory CD8(+)CD28(-) T-cells","volume":"8","author":"Neuber","year":"2017","journal-title":"Oncotarget"},{"issue":"6168","key":"10.1016\/j.ctarc.2021.100494_bib0119","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0120","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.4049\/jimmunol.1100978","article-title":"Reversible senescence in human CD4+CD45RA+CD27- memory T cells","volume":"187","author":"Di Mitri","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ctarc.2021.100494_bib0121","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.4049\/jimmunol.1301409","article-title":"IFN-alpha inhibits telomerase in human CD8(+) T cells by both hTERT downregulation and induction of p38 MAPK signaling","volume":"191","author":"Lanna","year":"2013","journal-title":"J. Immunol."},{"issue":"6824","key":"10.1016\/j.ctarc.2021.100494_bib0122","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0123","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ni1177","article-title":"Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases","volume":"6","author":"Salvador","year":"2005","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0124","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI38482","article-title":"Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans","volume":"119","author":"Bruns","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ctarc.2021.100494_bib0125","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2567.2010.03386.x","article-title":"Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process","volume":"132","author":"Libri","year":"2011","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.ctarc.2021.100494_bib0126","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2002-11-3577","article-title":"Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines","volume":"101","author":"Geginat","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0127","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1237327","article-title":"IL-15 enhances the antitumor effect of human antigen-specific CD8(+) T cells by cellular senescence delay","volume":"5","author":"Weng","year":"2016","journal-title":"Oncoimmunology"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0128","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.4049\/jimmunol.167.12.6869","article-title":"IL-7 enhances the survival and maintains the size of naive T cells","volume":"167","author":"Rathmell","year":"2001","journal-title":"J. Immunol"},{"issue":"7","key":"10.1016\/j.ctarc.2021.100494_bib0129","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20071681","article-title":"Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets","volume":"205","author":"Sportes","year":"2008","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100494_bib0130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Sportes","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ctarc.2021.100494_bib0131","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s13238-019-0643-y","article-title":"Chimeric antigen receptor T (CAR-T) cells expanded with IL-7\/IL-15 mediate superior antitumor effects","volume":"10","author":"Zhou","year":"2019","journal-title":"Protein Cell"},{"issue":"20","key":"10.1016\/j.ctarc.2021.100494_bib0132","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-20-0777","article-title":"Coexpression of IL7 and CCL21 increases efficacy of CAR-T cells in solid tumors without requiring preconditioned lymphodepletion","volume":"26","author":"Luo","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100494_bib0133","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100494_bib0134","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41375-017-0008-6","article-title":"PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells","volume":"32","author":"Zheng","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100494_bib0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/JES.0b013e318201f39d","article-title":"Aging, persistent viral infections, and immunosenescence: can exercise \"make space\"?","volume":"39","author":"Simpson","year":"2011","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.ctarc.2021.100494_bib0136","article-title":"Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial","volume":"12","author":"Hachmo","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"10.1016\/j.ctarc.2021.100494_bib0137","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1172\/JCI70355","article-title":"p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes","volume":"123","author":"Mondal","year":"2013","journal-title":"J. Clin. Invest."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:21:36Z","timestamp":1762842096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":137,"alternative-id":["S2468294221001908"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100494","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aging-associated immune system changes in multiple myeloma: The dark side of the moon.","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100494"}}